NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . March 30th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Vaccine Week | Other Publications

Cancer Gene Therapy - Studies from F. Mori et al in the area of cancer gene therapy described

Cancer Vaccines - New cancer vaccines study results reported from M. Fujita et al

Cancer Vaccines - Recent studies from Queen Mary Hospital add new data to cancer vaccines

Cancer Vaccines - Scientists at National Cancer Institute target cancer vaccines

 Vaccines - New data from University of Munich illuminate research in vaccines

Adenovirus - Researchers from McMaster University detail findings in adenovirus

Cancer Gene Therapy Vaccines - Data on cancer gene therapy vaccines described by C. Tosch et al

Cancer Vaccines - Medical Tourism - Choosing a Mexican Cancer Clinic

Cancer Vaccines - The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan

NKT Therapeutics, Inc. - NKT Therapeutics Closes Series a Venture Round Led by SV Life Sciences and MedImmune Ventures


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login